IKT
Inhibikase Therapeutics Inc
2.10$
-1.9%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Inhibikase Therapeutics Inc (IKT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.1 | -3.4 | -3.9 | -5.1 | -4.9 | -5.3 | -4.1 | -5.6 | -11 | -7.5 | -12 | -12 | -43 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.1 | 0.1 | 0.1 | 0.0 | 0.1 | 7.9 | 2.0 | 4.2 | 4.5 | 4.5 | 5.6 | 5.3 | 20 | |
| 0.3 | 0.6 | 0.7 | -0.1 | 0.7 | -1.1 | 1.3 | 0.5 | -2.1 | 0.4 | -0.1 | 3.4 | 1.6 | |
| 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.5 | 0.0 | 0.0 | 0.9 | |
| 17 | -2.1 | -3.3 | 2.5 | 2.5 | -39 | 21 | 9.8 | -29 | -0.1 | -80 | -5.9 | -115 | |
| – | 0.0 | – | – | – | – | – | – | – | – | – | – | – | |
| 0.0 | -0.1 | 0.4 | 3.2 | 0.2 | 100 | 0.0 | 0.0 | -0.1 | 109 | 2.9 | 0.0 | 111 | |
| 13 | -5.7 | -6.8 | 0.7 | -2.2 | 56 | 17 | 4.3 | -39 | 101 | -90 | -18 | -47 | |
| -4.1 | -3.4 | -3.9 | -5.1 | -4.9 | -5.3 | -4.1 | -5.6 | -11 | -8.0 | -12 | -12 | -43 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.